Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
December-2020 Volume 13 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2020 Volume 13 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Open Access

Update of in vitro, in vivo and ex vivo fluoro‑edenite effects on malignant mesothelioma: A systematic review (Review)

  • Authors:
    • Veronica Filetti
    • Ermanno Vitale
    • Giuseppe Broggi
    • Maria P. Hagnäs
    • Saverio Candido
    • Anna Spina
    • Claudia Lombardo
  • View Affiliations / Copyright

    Affiliations: Anatomy and Histology, Department of Biomedical and Biotechnological Sciences, University of Catania, I‑95123 Catania, Italy, Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, I‑95123 Catania, Italy, Pathologic Anatomy, Department ‘G.F. Ingrassia’, University of Catania, I‑95123 Catania, Italy, Rovaniemi Health Centre, 96200 Rovaniemi, Finland, Oncologic, Clinic and General Pathology Section, Department of Biomedical and Biotechnological Sciences, University of Catania, I‑95123 Catania, Italy, INPS Italian National Social Security Institution, I‑95129 Catania, Italy
    Copyright: © Filetti et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 60
    |
    Published online on: October 15, 2020
       https://doi.org/10.3892/br.2020.1367
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Fluoro‑edenite (FE), asbestiform fiber found in Biancavilla (Sicily, Italy), presents various characteristics similar to the asbestos group, in particular two fibrous phases tremolite and actinolite. Indeed, epidemiological studies have shown that FE fibers have similar effects to those of asbestos fibers. Such studies have reported a high incidence of malignant mesothelioma (MM), an aggressive neoplasm of the serosal membranes lining the pleural cavity, in individuals residing there due to FE exposure in Biancavilla related to environmental contamination. Evidence has led to the classification of FE as a Group 1 human carcinogen by the International Agency for Research on Cancer (IARC). The aim of this systematic review is to compare the results achieved in in vitro, in vivo and ex vivo experimental studies involving FE in order to update the current knowledge on the pathogenesis and molecular mechanisms responsible for FE‑mediated MM development as well as the availability of effective biomarkers for MM prevention and diagnosis. This review is focused on the pathophysiological mechanisms mediated by inflammation induced by FE fiber exposure and which are responsible for MM development. This review also discusses the discovery of new diagnostic and prognostic biomarkers for the management of this pathology. It is known that the risk of cancer development increases with chronic inflammation, arising from enhanced reactive oxygen species (ROS) and NO• production stimulated by the body to remove exogenous agents, causing DNA damage and enhanced signal transduction that may lead to activation of oncogenes. Studies concerning MM biomarker discovery indicate that several biomarkers have been proposed for MM, but mesothelin is the only Food and Drug Administration (FDA)‑approved biomarker for MM, with limitations. In recent studies, in silico analysis to identify selected miRNAs highly deregulated in cancer samples when compared with normal control have been developed. This in silico approach could represent an effort in the field of biomarker discovery for MM.
View Figures

Figure 1

Figure 2

View References

1 

Hansen J, De Klerk NH, Eccles JL, Musk AW and Hobbs MS: Malignant mesothelioma after environmental exposure to blue asbestos. Int J Cancer. 54:578–581. 1993.PubMed/NCBI View Article : Google Scholar

2 

Kanarek MS: Mesothelioma from chrysotile asbestos: Update. Ann Epidemiol. 21:688–697. 2011.PubMed/NCBI View Article : Google Scholar

3 

Bayram M, Dongel I, Bakan ND, Yalççn H, Cevit R, Dumortier P and Nemery B: High risk of malignant mesothelioma and pleural plaques in subjects born close to ophiolites. Chest. 143:164–171. 2013.PubMed/NCBI View Article : Google Scholar

4 

Carbone M, Kanodia S, Chao A, Miller A, Wali A, Weissman D, Adjei A, Baumann F, Boffetta P, Buck B, et al: Consensus report of the 2015 weinman international conference on mesothelioma. J Thorac Oncol. 11:1246–1262. 2016.PubMed/NCBI View Article : Google Scholar

5 

Case BW, Abraham JL, Meeker G, Pooley FD and Pinkerton KE: Applying definitions of ‘asbestos’ to environmental and ‘low-dose’ exposure levels and health effects, particularly malignant mesothelioma. J Toxicol Environ Health B Crit Rev. 14:3–39. 2011.PubMed/NCBI View Article : Google Scholar

6 

Huang SX, Jaurand MC, Kamp DW, Whysner J and Hei TK: Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. J Toxicol Environ Health B Crit Rev. 14:179–245. 2011.PubMed/NCBI View Article : Google Scholar

7 

Liu G, Cheresh P and Kamp DW: Molecular basis of asbestos-induced lung disease. Annu Rev Pathol. 8:161–187. 2013.PubMed/NCBI View Article : Google Scholar

8 

Ledda C, Pomara C, Bracci M, Mangano D, Ricceri V, Musumeci A, Ferrante M, Musumeci G, Loreto C, Fenga C, et al: Natural carcinogenic fiber and pleural plaques assessment in a general population: A cross-sectional study. Environ Res. 150:23–29. 2016.PubMed/NCBI View Article : Google Scholar

9 

Falzone L, Marconi A, Loreto C, Franco S, Spandidos DA and Libra M: Occupational exposure to carcinogens: Benzene, pesticides and fibers (Review). Mol Med Rep. 14:4467–4474. 2016.PubMed/NCBI View Article : Google Scholar

10 

Gangemi S, Rapisarda V, Minciullo PL, Di Pasquale G, Lombardo G, Valentino M and Fenga C: Circulating levels of interleukin-18 in asbestos-exposed workers. Toxicol Ind Health. 21:125–129. 2005.

11 

Aitio A, Cantor KP, Attfield MD, Demers PA, Fowler BA, Grandjean P, Fubini B, Hartwig A, Gérin M, et al: A review of human carcinogens: Arsenic, metals, fibres and dusts. Vol 100 C. IARC, Lyon, pp219-224, 2012.

12 

Travaglione S, Bruni B, Falzano I, Paoletti I and Fiorentini C: Effects of the new-identified amphibole FE in lung epithelial cells. Toxicol In Vitro. 17:547–552. 2003.

13 

Pikarsky E, Porat RM, Stein I, Abramovitch R, Admit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and Ben-Neriah Y: NF-kappaB function as a tumor promoter in inflammation-associated cancer. Nature. 431:461–466. 2004.PubMed/NCBI View Article : Google Scholar

14 

Tokokuni S: Mechanisms of asbestos-induced carcinogenesis. Nagoya J Med Sci. 71:1–10. 2009.PubMed/NCBI

15 

Koskinen K, Rinne JP, Zitting A, Tossavainen A, Kivekäs J, Reijula K, Roto P and Huuskonen MS: Screening for asbestos-induced diseases in Finland. Am J Ind Med. 30:241–251. 1996.PubMed/NCBI View Article : Google Scholar

16 

Pan XL, Day HW, Wang W, Beckett LA and Schenker MB: Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med. 172:1019–1025. 2005.PubMed/NCBI View Article : Google Scholar

17 

Luo S, Liu X, Mu S, Tsai SP and Wen CP: Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data. Occup Environ Med. 60:35–41. 2003.PubMed/NCBI View Article : Google Scholar

18 

Baumann F, Maurizot P, Mangeas M, Ambrosi JP, Douwes J and Robineau B: Pleural mesothelioma in New Caledonia: Associations with environmental risk factors. Environ Health Perspect. 119:695–700. 2011.PubMed/NCBI View Article : Google Scholar

19 

Rey F, Boutin C, Steinbauer J, Viallat JR, Alessandroni P, Jutisz P, Di Giambattista D, Billon-Galland MA, Hereng P, Dumortier P, et al: Environmental pleural plaques in an asbestos exposed population of northeast Corsica. Eur Respir J. 6:978–982. 1993.PubMed/NCBI

20 

McConnochie K, Simonato L, Mavrides P, Christofides P, Pooley FD and Wagner JC: Mesothelioma in Cyprus: The role of tremolite. Thorax. 42:342–347. 1987.PubMed/NCBI View Article : Google Scholar

21 

Constantopoulos SH: Environmental mesothelioma associated with tremolite asbestos: Lessons from the experiences of Turkey, Greece, Corsica, New Caledonia and Cyprus. Regul Toxicol Pharmacol. 52 (1 Suppl):S110–S115. 2008.PubMed/NCBI View Article : Google Scholar

22 

Baris YI, Artvinli M, Sahin AA, Sebastien P and Gaudichet A: Diffuse lung fibrosis due fibrous zeolite (erionite) exposure. Eur J Respir Dis. 70:122–125. 1987.PubMed/NCBI

23 

Yazicioglu S, Ilçayto R, Balci K, Sayli BS and Yorulmaz B: Pļeural calcification, pleural mesotheliomas, and bronchial cancers caused by tremolite dust. Thorax. 35:564–569. 1980.PubMed/NCBI View Article : Google Scholar

24 

Dumortier P, Coplü L, de Maertelaer V, Emri S, Baris I and De Vuyst P: Assessment of environmental asbestos exposure in Turkey by bronchoalveolar lavage. Am J Respir Crit Care Med. 158:1815–1824. 1998.PubMed/NCBI View Article : Google Scholar

25 

Senyigit A, Dalgic A, Kavak O and Tanrikulu AC: Determination of environmental exposure to asbestos (tremolite) and mesothelioma risks in the southeastern region of Turkey. Arch Environ Health. 59:658–662. 2004.PubMed/NCBI View Article : Google Scholar

26 

Metintas M, Metintas S, Hillerdal G, Ucgun I, Erginel S, Alatas F and Yildirim H: Non malignant pleural lesions due to environmental exposure to asbestos: A field-based, cross-sectional study. Eur Respir J. 26:875–880. 2005.PubMed/NCBI View Article : Google Scholar

27 

Döngel I, Bayram M, Bakan ND, Yalçın H and Gültürk S: Is living close to ophiolites related to asbestos related diseases? Cross-sectional study. Respir Med. 107:870–874. 2013.PubMed/NCBI View Article : Google Scholar

28 

Kliment CR, Clemens K and Oury TD: North American erionite-associated mesothelioma with pleural plaques and pulmonary fibrosis: A case report. Int J Clin Exp Pathol. 2:407–410. 2009.PubMed/NCBI

29 

Baumann F, Buck BJ, Metcalf RV, McLaurin BT, Merkler DJ and Carbone M: The presence of asbestos in the natural environment is likely related to mesothelioma in young individuals and women from southern Nevada. J Thorac Oncol. 10:731–737. 2015.PubMed/NCBI View Article : Google Scholar

30 

Konen T, Johnson JE, Lindgren P and Williams A: Cancer incidence and mortality associated with non-occupational and low dose exposure to Libby vermiculite in Minnesota. Environ Res. 175:449–456. 2019.PubMed/NCBI View Article : Google Scholar

31 

Baur X: Review on the adverse health effects of asbestiform antigorite, a non-regulated asbestiform serpentine mineral. Am J Ind Med. 61:625–630. 2018.PubMed/NCBI View Article : Google Scholar

32 

Cardile V, Lombardo L, Belluso E, Panico A, Capella S and Balazy M: Toxicity and carcinogenicity mechanisms of fibrous antigorite. Int J Environ Res Public Health. 4:1–9. 2007.PubMed/NCBI View Article : Google Scholar

33 

Groppo C and Compagnoni R: Ubiquitous fibrous antigorite veins from the Lanzo Ultramafic Massif, Internal Western Alps (Italy): Characterisation and genetic conditions. Per Mineral. 76:169–181. 2007.

34 

FitzGerald J, Eggleton R and Keeling J: Antigorite from Rowland flat, South Australia: Asbestiform character. Eur J Mineral. 22:525–533. 2010.

35 

Fitzgerald SM and Harty EA: Antigorite: Is it the forgotten asbestos? Prof Saf. 59:43–48. 2014.

36 

Soffritti M, Minardi F, Bua L, Degli Esposti D and Belpoggi F: First experimental evidence of peritoneal and pleural mesotheliomas induced by FE fibres present in Etnean volcanic material from Biancavilla (Sicily, Italy). Eur J Oncol. 9:169–715. 2004.

37 

Gianfagna A and Oberti R: Fluoro-edenite from Biancavilla (Catania, Sicily, Italy): Crystal chemistry of a new amphibole end-member. Am Mineral. 86:1489–1493. 2001.

38 

Biggeri A, Pasetto R, Belli S, Bruno C, Di Maria G, Mastrantonio M, Trinca S, Uccelli R and Comba P: Mortality from chronic obstructive pulmonary disease and pleural mesothelioma in an area contaminated by natural fiber (fluoro-edenite). Scand J Work Environ Health. 30:249–252. 2004.PubMed/NCBI View Article : Google Scholar

39 

Comba P, Gianfagna A and Paoletti L: Pleural mesothelioma cases in Biancavilla are related to a new fluoro-edenite fibrous amphibole. Arch Environ Health. 58:229–232. 2003.PubMed/NCBI View Article : Google Scholar

40 

Gianfagna A, Ballirano P, Bellatreccia F, Bruni B, Paoletti L and Oberti R: Characterization of amphibole fibres linked to mesothelioma in the area of Biancavilla, Eastern Sicily, Italy. Mineral Mag. 67:1221–1229. 2003.

41 

Ledda C, Costa C, Matera S, Puglisi B, Costanzo V, Bracci M, Fenga C, Rapisarda V and Loreto C: Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers. Mol Med Rep. 15:3372–3378. 2017.PubMed/NCBI View Article : Google Scholar

42 

Ledda C and Rapisarda V: Malignant pleural mesothelioma: The need to move from research to clinical practice. Arch Med Res. 47(407)2016.PubMed/NCBI View Article : Google Scholar

43 

Martinez G, Loreto C, Rapisarda V, Musumeci G, Valentino M and Carnazza ML: Effects of exposure to fluoro-edenite fibre pollution on the respiratory system: An in vivo model. Histol Histopathol. 21:595–601. 2006.PubMed/NCBI View Article : Google Scholar

44 

Caltabiano R, Loreto C, Vitale E, Matera S, Miozzi E, Migliore M, Angelico G, Tumino R, Ledda C and Rapisarda V: Fibulin-3 immunoexpression in malignant mesothelioma due to fluoro-edenite: A preliminary report. Future Oncol. 14 (6 Suppl):S53–S57. 2018.PubMed/NCBI View Article : Google Scholar

45 

Paoletti L, Batisti D, Bruno C, Di Paola M, Gianfagna A, Mastrantonio M, Nesti M and Comba P: Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: An epidemiological and environmental study. Arch Environ Health. 55:392–398. 2000.PubMed/NCBI View Article : Google Scholar

46 

Di Paola M, Mastrantonio M, Carboni M, Belli S, Grignoli M, Comba P and Nesti M: Mortality from malignant pleural neoplasms in Italy in the years 1988-1992. Rapporti ISTISAN, 96/40. Istituto Superiore di Sanità, Rome, 1996.

47 

Fazzo L, De Santis M, Minelli G, Bruno C, Zona A, Marinaccio A, Conti S and Comba P: Pleural mesothelioma mortality and asbestos exposure mapping in Italy. Am J Industr Med. 55:11–24. 2012.PubMed/NCBI View Article : Google Scholar

48 

Fazzo L, Minelli G, De Santis M, Bruno C, Zona A, Marinaccio A, Conti S, Pirastu R and Comba P: Mesothelioma mortality surveillance and asbestos exposure tracking in Italy. Ann Ist Super Sanita. 48:300–310. 2012.PubMed/NCBI View Article : Google Scholar

49 

Rapisarda V, Ledda C, Ricceri V, Arena F, Musumeci A, Marconi A, Fago L, Bracci M, Santarelli L and Ferrante M: Detection of pleural plaques in workers exposed to inhalation of natural fluoro-edenite fibres. Oncol Lett. 9:2046–2052. 2015.PubMed/NCBI View Article : Google Scholar

50 

Ledda C, Loreto C, Matera S, Massimino N, Cannizzaro E, Musumeci A, Migliore M, Fenga C, Pomara C and Rapisarda V: Early effects of fluoro-edenite: Correlation between IL-18 serum levels and pleural and parenchymal abnormalities. Future Oncol. 12 (23 Suppl):S59–S62. 2016.PubMed/NCBI View Article : Google Scholar

51 

Grosse Y, Loomis D, Guyton KZ, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Scoccianti C, Mattock H and Straif K: Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes. Lancet Oncol. 15:1427–1428. 2014.PubMed/NCBI View Article : Google Scholar

52 

Miller SA: PICO worksheet and search strategy. National Center for Dental Hygiene Research, 2001.

53 

Fenoglio I, Croce A, Di Renzo F, Tiozzo R and Fubini B: Pure-silica zeolites (Porosils) as model solids for the evaluation of the physicochemical features determining silica toxicity to macrophages. Chem Res Toxicol. 13:489–500. 2000.PubMed/NCBI View Article : Google Scholar

54 

Pugnaloni A, Lucarini G, Giantomassi F, Lombardo L, Capella S, Belluso E, Zizzi A, Panico AM, Biagini G and Cardile V: In vitro study of biofunctional indicators after exposure to asbestos-like fluoro-edenite fibres. Cell Mol Biol (Noisy-le-grand). 53 (Suppl):OL965–OL980. 2007.PubMed/NCBI

55 

Tremblay GM, Jordana M, Gauldie J and Särnstrand B: Fibroblasts as effector cells in fibrosis. In: Pulmonary fibrosis. Phan SH and Thrall RS (eds). Marcel Dekker Inc., New York, NY, pp541-577, 1995.

56 

Travaglione S, Bruni BM, Falzano L, Filippini P, Fabbri A, Paoletti L and Fiorentini C: Multinucleation and pro-inflammatory cytokine release promoted by fibrous fluoro-edenite in lung epithelial A549 cells. Toxicol in Vitro. 20:841–850. 2006.PubMed/NCBI View Article : Google Scholar

57 

Li XY, Lamb D and Donaldson K: The production of TNF-alpha and IL-1-like activity by bronchoalveolar leucocytes after intratracheal instillation of crocidolite asbestos. Int J Exp Pathol. 74:403–410. 1993.PubMed/NCBI

58 

Trimblin C, BeruBe K, Churg A, Driscoll K, Gordon T, Hemenway D, Walsh E, Cummins AB, Vacek P and Mossman B: Ambient particulate matter causes activation of the c-jun kinase/stress-activated protein kinase cascade and DNA synthesis in lung epithelial cells. Cancer Res. 58:4543–4547. 1998.PubMed/NCBI

59 

Hedges S, Svensson M, Agace W and Svanborg C: Cytokines induce an epithelial cell cytokine response. Adv Exp Med Biol. 371A:189–193. 1995.PubMed/NCBI View Article : Google Scholar

60 

Cardile V, Proietti L, Panico A and Lombardo L: Nitric oxide production in fluoro-edenite treated mouse monocyte-macrophage cultures. Oncol Rep. 12:1209–1215. 2004.PubMed/NCBI

61 

Hedenborg M and Klockars M: Production of reactive oxygen metabolites induced by asbestos fibres in human polymorphonuclear leucocytes. J Clin Pathol. 40:1189–1193. 1987.PubMed/NCBI View Article : Google Scholar

62 

Hamilton RF, Iyer LL and Holian A: Asbestos induces apoptosis in human alveolar macrophages. Am J Physiol. 271:L813–L819. 1996.PubMed/NCBI View Article : Google Scholar

63 

Loreto C, Carnazza ML, Cardile V, Libra M, Lombardo L, Malaponte G, Martinez G, Musumeci G, Papa V and Cocco L: Mineral fiber-mediated activation of phosphoinositide-specific phospholipase c in human bronchoalveolar carcinoma-derived alveolar epithelial A549 cells. Int J Oncol. 34:371–376. 2009.PubMed/NCBI

64 

Cardile V, Renis M, Scifo C, Lombardo L, Gulino R, Mancari B and Panico A: Behaviour of the new asbestos amphibole fluor-edenite in different lung cell systems. Int J Biochem Cell Biol. 36:849–860. 2004.PubMed/NCBI View Article : Google Scholar

65 

Pӓӓkkӧ P, Rämet M, Vähäkangas K, Korpela N, Soini Y, Turunen S, Jaworska M and Gillissen A: Crocidolite asbestos causes an induction of p53 and apoptosis in cultured A-549 lung carcinoma cells. Apoptosis. 3:203–212. 1998.PubMed/NCBI View Article : Google Scholar

66 

Yang CM, Luo SF, Wang CC, Chiu CT, Chien CS, Lin CC and Hsiao LD: Tumour necrosis factor-alpha- and interleukin-1beta-stimulated cell proliferation through activation of mitogen-activated protein kinase in canine tracheal smooth muscle cells. Br J Pharmac. 130:891–899. 2000.PubMed/NCBI View Article : Google Scholar

67 

Rana Rs and Hokin LE: Role of phosphoinositides in trans-membrane signaling. Physiol Rev. 70:115–164. 1990.PubMed/NCBI View Article : Google Scholar

68 

Lim Y, Kim SH, Kim KA, Oh MW and Lee KH: Involvement of protein kinase C, phospholipase C, and protein tyrosine kinase pathways in oxygen radical generation by asbestos-stimulated alveolar macrophage. Environ Health Perspect. 105 (Suppl 5):S1325–S1327. 1997.PubMed/NCBI View Article : Google Scholar

69 

Musumeci G, Cardile V, Fenga C, Caggia S and Loreto C: Mineral fibre toxicity: Expression of retinoblastoma (Rb) and phospho-retinoblastoma (pRb) protein in alveolar epithelial and mesothelial cell lines exposed to fluoro-edenite fibres. Cell Biol Toxicol. 27:217–225. 2011.PubMed/NCBI View Article : Google Scholar

70 

Beachy PA, Karhadkar SS and Berman DM: Tissue repair and stem cell renewal in carcinogenesis. Nature. 432:324–331. 2004.PubMed/NCBI View Article : Google Scholar

71 

Chen S, Guttrige DC, You Z, Zhang Z, Fribley A, Mayo MW, Kitajewski J and Wang CY: Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol. 152:87–96. 2001.PubMed/NCBI View Article : Google Scholar

72 

Zheng R, Yano S, Matsumori Y, Nakataki E, Muguruma H, Yoshizumi M and Sone S: SRC tyrosine kinase inhibitor, m475271, suppresses subcutaneous growth and production of lung metastasis via inhibition of proliferation, invasion, and vascularization of human lung adenocarcinoma cells. Clin Exp Metastasis. 22:195–204. 2005.PubMed/NCBI View Article : Google Scholar

73 

Yamanouchi H, Furihata M, Fujita JJ, Murakami H, Yoshinouchi T, Takahara J and Ohtsuki Y: Expression of cyclin E and cyclin D1 in non-small cell lung cancers. Lung Cancer. 31:3–8. 2001.PubMed/NCBI View Article : Google Scholar

74 

Rapisarda V, Salemi R, Marconi A, Loreto C, Graziano AC, Cardile V, Basile MS, Candido S, Falzone L, Spandidos DA, et al: Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells. Oncol Lett. 12:3363–3367. 2016.PubMed/NCBI View Article : Google Scholar

75 

Chu IM, Hengst L and Slingerland JM: The Cdk inhibitor p27 in human cancer: Prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 8:253–267. 2008.PubMed/NCBI View Article : Google Scholar

76 

Rapisarda V, Caltabiano R, Musumeci G, Castrogiovanni P, Ferrante M, Ledda C, Lombardo C, Graziano ACE, Cardile V and Loreto C: Analysis of fibulin-3 after exposure to asbestos-like fibers. Environ Res. 156:381–387. 2017.PubMed/NCBI View Article : Google Scholar

77 

Filetti V, Falzone L, Rapisarda V, Caltabiano R, Graziano ACE, Ledda C and Loreto C: Modulation of microRNA expression levels after naturally occurring asbestiform fibers exposure as a diagnostic biomarker of mesothelial neoplastic transformation. Ecotoxicol Environ Saf. 198(110640)2020.PubMed/NCBI View Article : Google Scholar

78 

Cardile V, Lombardo L, Belluso E, Panico A, Renis M, Gianfagna A and Balazy M: Fluoro-edenite fibers induce expression of Hsp70 and inflammatory response. Int J Environ Res Public Health. 4:195–202. 2007.PubMed/NCBI View Article : Google Scholar

79 

Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q and Mossman B: Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free radical Biol Med. 34:1117–1129. 2003.PubMed/NCBI View Article : Google Scholar

80 

Holian A, Kelley K and Hamilton RF Jr: Mechanisms associated with human alveolar macrophage stimulation by particulates. Environ Health Perspect. 102 (Suppl 10):S69–S74. 1994.PubMed/NCBI View Article : Google Scholar

81 

De Witt DL: Prostaglandin endoperoxide synthase: Regulation of enzyme expression. Biochim Byophys Acta. 1083:121–134. 1991.PubMed/NCBI View Article : Google Scholar

82 

DeNardo P, Bruni B, Paoletti L, Pasetto R and Sirianni B: Pulmonary fibre burden in sheep living in the Biancavilla area (Sicily): Preliminary results. Sci Total Environ. 325:51–58. 2004.PubMed/NCBI View Article : Google Scholar

83 

Loreto C, Rapisarda V, Carnazza ML, Musumeci G, Valentino M, Fenga C and Martinez G: Fluoro-edenite fibres induce lung cell apoptosis: An in vivo study. Histol Histopathol. 23:319–326. 2008.PubMed/NCBI View Article : Google Scholar

84 

Musumeci G, Loreto C, Cardile V, Carnazza ML and Martinez G: Immunohistochemical expression of retinoblastoma and phospho-retinoblastoma protein in sheep lung exposed to fluoro-edenite fibers. Anat Sci Int. 85:74–78. 2010.PubMed/NCBI View Article : Google Scholar

85 

Musumeci G, Loreto C, Giunta S, Rapisarda V, Szychlinska MA, Imbesi R, Castorina A, Annese T, Castorina S, Castrogiovanni P and Ribatti D: Angiogenesis correlates with macrophage and mast cell infiltration in lung tissue of animals exposed to fluoro-edenite fibers. Exp Cell Res. 346:91–98. 2016.PubMed/NCBI View Article : Google Scholar

86 

Loreto C, Lombardo C, Caltabiano R, Ledda C, Hagnas M, Filetti V and Rapisarda V: An in vivo immunohistochemical study on MacroH2A.1 in lung and lymph-node tissues exposed to an asbestiform fiber. Curr Mol Med: Feb 20, 2020 (Epub ahead of print).

87 

Ledda C, Loreto C, Pomara C, Rapisarda G, Fiore M, Ferrante M, Bracci M, Santarelli L, Fenga C and Venerando R: Sheep lymph-nodes as a biological indicator of environmental exposure to fluoro-edenite. Environ Res. 147:97–101. 2016.PubMed/NCBI View Article : Google Scholar

88 

Belpoggi F, Tibaldi E, Lauriola M, Bua L, Falcioni L, Chiozzotto D, Manservisi F, Manservigi M and Soffritti M: The efficacy of long-term bioassays in predicting human risks: Mesotheliomas induced by fluoro-edenite fibres present in lava stone from the Etna volcano in Biancavilla, Italy. Eur J Oncol. 16:185–196. 2011.

89 

Begin R, Rola-Pleszczynski M, Sirois P, Masse S, Nadeau D and Bureau MA: Sequential analysis of the bronchoalveolar milieu in conscious sheep. J Appl Physiol Resp Envir Exerc Physiol. 50:665–671. 1981.PubMed/NCBI View Article : Google Scholar

90 

Schlesinger RB: Clearance from the respiratory tract. Fundam Appl Toxicol. 5:435–450. 1985.PubMed/NCBI View Article : Google Scholar

91 

Dumortier P, Rey F, Viallat JR, Broucke I, Boutin C and De Vuyst P: Chrysotile and tremolite asbestos fibres in the lungs and parietal pleura of Corsican goats. Occup Env Med. 59:643–646. 2002.PubMed/NCBI View Article : Google Scholar

92 

Musumeci G, Loreto C, Szychlinska MA, Imbesi R, Rapisarda V, Aiello FC, Castorina S and Castrogiovanni P: N-Cadherin, ADAM-10 and Aquaporin 1 expression in lung tissue exposed to fluoro-edenite fibers: An immunohistochemical study. Histol Histopathol. 30:987–999. 2015.PubMed/NCBI View Article : Google Scholar

93 

Rapisarda V, Rapisarda G, Vico CD, Gobbi L, Loreto C and Valentino M: Monitoring of fluoro-edenite fibre pollution through the study of sheep lymph nodes as a model of a biological indicator. Occup Environ Med. 62(656)2005.PubMed/NCBI View Article : Google Scholar

94 

Angelico G, Caltabiano R, Loreto C, Ieni A, Tuccari G, Ledda C and Rapisarda V: Immunohistochemical expression of aquaporin-1 in fluoro-edenite-induced malignant mesothelioma: A preliminary report. Int J Mol Sci. 19(685)2018.PubMed/NCBI View Article : Google Scholar

95 

Ledda C, Caltabiano R, Loreto C, Cinà D, Senia P, Musumeci A, Ricceri V, Pomara C and Rapisarda V: Prevalence of anti-nuclear autoantibodies in subjects exposed to natural asbestiform fibers: A cross-sectional study. J Immunotoxicol. 15:24–28. 2018.PubMed/NCBI View Article : Google Scholar

96 

Rapisarda V, Loreto C, Castorina S, Romano G, Garozzo SF, Musumeci A, Migliore M, Avola R, Cinà D, Pomara C and Ledda C: Occupational exposure to fluoro-edenite and prevalence of anti-nuclear autoantibodies. Future Oncol. 14 (6 Suppl):S59–S62. 2018.PubMed/NCBI View Article : Google Scholar

97 

Baas P, Fennell D, Kerr KM, van Schil PE, Haas RL and Peters S: ESMO Guidelines Committee. Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 26 (Suppl 5):v31–v39. 2015.PubMed/NCBI View Article : Google Scholar

98 

Ying S, Jiang Z, He X, Yu M, Chen R, Chen J, Ru G, Chen Y, Chen W, Zhu L, et al: Serum HMGB1 as a potential biomarker for patients with asbestos-related diseases. Dis Markers. 2017(5756102)2017.PubMed/NCBI View Article : Google Scholar

99 

Tomasson K, Gudmundsson G, Briem H and Rafnsson V: Malignant mesothelioma incidence by nation-wide cancer registry: A population-based study. J Occup Med Toxicol. 11(37)2016.PubMed/NCBI View Article : Google Scholar

100 

Cui A, Jin XG, Zhai K, Tong ZH and Shi HZ: Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: Updated meta-analysis. BMJ Open. 4(e004145)2014.PubMed/NCBI View Article : Google Scholar

101 

Arnold DT and Maskell NA: Biomarkers in mesothelioma. Ann Clin Biochem. 55:49–58. 2018.PubMed/NCBI View Article : Google Scholar

102 

Wu T, Zhang W, Yang G, Li H, Chen Q, Song R and Zhao L: HMGB1 overexpression as a prognostic factor for survival in cancer: A meta-analysis and systematic review. Oncotarget. 7:50417–50427. 2016.PubMed/NCBI View Article : Google Scholar

103 

Creaney J, Sneddon S, Dick IM, Dare H, Boudville N, Musk AW, Skates SJ and Robinson BW: Comparison of the diagnostic accuracy of the MSLN gene products, mesothelin and megakaryocyte potentiating factor, as biomarkers for mesothelioma in pleural effusions and serum. Dis Markers. 35:119–127. 2013.PubMed/NCBI View Article : Google Scholar

104 

Creaney J, Dick IM, Meniawy TM, Leong SL, Leon JS, Demelker Y, Segal A, Musk AW, Lee YC, Skates SJ, et al: Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma. Thorax. 69:895–902. 2014.PubMed/NCBI View Article : Google Scholar

105 

Chen Z, Gaudino G, Pass HI, Carbone M and Yang H: Diagnostic and prognostic biomarkers for malignant mesothelioma: An update. Transl Lung Cancer Res. 6:259–269. 2017.PubMed/NCBI View Article : Google Scholar

106 

Boudville N, Paul R, Robinson BW and Creaney J: Mesothelin and kidney function-analysis of relationship and implications for mesothelioma screening. Lung Cancer. 73:320–324. 2011.PubMed/NCBI View Article : Google Scholar

107 

Lim CB, Prêle CM, Cheah HM, Cheng YY, Klebe S, Reid G, Watkins DN, Baltic S, Thompson PJ and Mutsaers SE: Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma. PLoS One. 8(e66685)2013.PubMed/NCBI View Article : Google Scholar

108 

Shi Y, Moura U, Opitz I, Soltermann A, Rehrauer H, Thies S, Weder W, Stahel RA and Felley-Bosco E: Role of hedgehog signaling in malignant pleural mesothelioma. Clin Cancer Res. 18:4646–4656. 2012.PubMed/NCBI View Article : Google Scholar

109 

Candido S, Lupo G, Pennisi M, Basile MS, Anfuso CD, Petralia MC, Gattuso G, Vivarelli S, Spandidos DA, Libra M and Falzone L: The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease. Oncol Rep. 42:911–922. 2019.PubMed/NCBI View Article : Google Scholar

110 

Falzone L, Romano GL, Salemi R, Bucolo C, Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M and Candido S: Prognostic significance of deregulated microRNAs in uveal melanomas. Mol Med Rep. 19:2599–2610. 2019.PubMed/NCBI View Article : Google Scholar

111 

Nikolouzakis TK, Vassilopoulou L, Fragkiadaki P, Mariolis Sapsakos T, Papadakis GZ, Spandidos DA, Tsatsakis AM and Tsiaoussis J: Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review). Oncol Rep. 39:2455–2472. 2018.PubMed/NCBI View Article : Google Scholar

112 

Ledda C, Senia P and Rapisarda V: Biomarkers for early diagnosis and prognosis of malignant pleural mesothelioma: The quest goes on. Cancers (Basel). 10(203)2018.PubMed/NCBI View Article : Google Scholar

113 

De Santi C, Melaiu O, Bonotti A, Cascione L, Di Leva G, Foddis R, Cristaudo A, Lucchi M, Mora M, Truini A, et al: Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism. Sci Rep. 7(3140)2017.PubMed/NCBI View Article : Google Scholar

114 

Martínez-Rivera V, Negrete-García MC, Ávila-Moreno F and Ortiz-Quintero B: Secreted and tissue miRNAs as diagnosis biomarkers of malignant pleural mesothelioma. Int J Mol Sci. 19(595)2018.PubMed/NCBI View Article : Google Scholar

115 

Falzone L, Candido S, Salemi R, Basile MS, Scalisi A, McCubrey JA, Torino F, Signorelli SS and Montella M: Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer. Oncotarget. 7:72758–72766. 2016.PubMed/NCBI View Article : Google Scholar

116 

Falzone L, Scola L, Zanghì A, Biondi A, Di Cataldo A, Libra M and Candido S: Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development. Aging (Albany NY). 10:1000–1014. 2018.PubMed/NCBI View Article : Google Scholar

117 

Hafsi S, Candido S, Maestro R, Falzone L, Soua Z, Bonavida B, Spandidos DA and Libra M: Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study. Oncol Lett. 11:1021–1025. 2016.PubMed/NCBI View Article : Google Scholar

118 

Polo A, Crispo A, Cerino P, Falzone L, Candido S, Giudice A, De Petro G, Ciliberto G, Montella M, Budillon A and Costantini S: Environment and bladder cancer: Molecular analysis by interaction networks. Oncotarget. 8:65240–65252. 2017.PubMed/NCBI View Article : Google Scholar

119 

Salemi R, Falzone L, Madonna G, Polesel J, Cinà D, Mallardo D, Ascierto PA, Libra M and Candido S: MMP-9 as a candidate marker of response to BRAF inhibitors in melanoma patients with BRAFV600E mutation detected in circulating-free DNA. Front Pharmacol. 9(856)2018.PubMed/NCBI View Article : Google Scholar

120 

Cavallari I, Urso L, Sharova E, Pasello G and Ciminale V: Liquid biopsy in malignant pleural mesothelioma: State of the art, pitfalls, and perspectives. Front Oncol. 9(740)2019.PubMed/NCBI View Article : Google Scholar

121 

Tuaeva NO, Falzone L, Porozov YB, Nosyrev AE, Trukhan VM, Kovatsi L, Spandidos DA, Drakoulis N, Kalogeraki A, Mamoulakis C, et al: Translational application of circulating DNA in oncology: Review of the last decades achievements. Cells. 8(1251)2019.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Filetti V, Vitale E, Broggi G, Hagnäs MP, Candido S, Spina A and Lombardo C: Update of in vitro, in vivo and ex vivo fluoro‑edenite effects on malignant mesothelioma: A systematic review (Review). Biomed Rep 13: 60, 2020.
APA
Filetti, V., Vitale, E., Broggi, G., Hagnäs, M.P., Candido, S., Spina, A., & Lombardo, C. (2020). Update of in vitro, in vivo and ex vivo fluoro‑edenite effects on malignant mesothelioma: A systematic review (Review). Biomedical Reports, 13, 60. https://doi.org/10.3892/br.2020.1367
MLA
Filetti, V., Vitale, E., Broggi, G., Hagnäs, M. P., Candido, S., Spina, A., Lombardo, C."Update of in vitro, in vivo and ex vivo fluoro‑edenite effects on malignant mesothelioma: A systematic review (Review)". Biomedical Reports 13.6 (2020): 60.
Chicago
Filetti, V., Vitale, E., Broggi, G., Hagnäs, M. P., Candido, S., Spina, A., Lombardo, C."Update of in vitro, in vivo and ex vivo fluoro‑edenite effects on malignant mesothelioma: A systematic review (Review)". Biomedical Reports 13, no. 6 (2020): 60. https://doi.org/10.3892/br.2020.1367
Copy and paste a formatted citation
x
Spandidos Publications style
Filetti V, Vitale E, Broggi G, Hagnäs MP, Candido S, Spina A and Lombardo C: Update of in vitro, in vivo and ex vivo fluoro‑edenite effects on malignant mesothelioma: A systematic review (Review). Biomed Rep 13: 60, 2020.
APA
Filetti, V., Vitale, E., Broggi, G., Hagnäs, M.P., Candido, S., Spina, A., & Lombardo, C. (2020). Update of in vitro, in vivo and ex vivo fluoro‑edenite effects on malignant mesothelioma: A systematic review (Review). Biomedical Reports, 13, 60. https://doi.org/10.3892/br.2020.1367
MLA
Filetti, V., Vitale, E., Broggi, G., Hagnäs, M. P., Candido, S., Spina, A., Lombardo, C."Update of in vitro, in vivo and ex vivo fluoro‑edenite effects on malignant mesothelioma: A systematic review (Review)". Biomedical Reports 13.6 (2020): 60.
Chicago
Filetti, V., Vitale, E., Broggi, G., Hagnäs, M. P., Candido, S., Spina, A., Lombardo, C."Update of in vitro, in vivo and ex vivo fluoro‑edenite effects on malignant mesothelioma: A systematic review (Review)". Biomedical Reports 13, no. 6 (2020): 60. https://doi.org/10.3892/br.2020.1367
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team